Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Verastem. United States. Announced Date 17/07/2013. Closed Date 22/07/2013. Deal value: $56m. Confidentially marketed public offering. Industry: Verastem is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients.